Middle Aged
Conditions
Keywords
Text message, Podcast, Well-being, Physical activity
Brief summary
This is a randomized, controlled pilot trial (N=30) to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults.
Detailed description
This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults. In Move with Meaning, participants will listen to weekly audio sessions and complete twice weekly text message sessions, in which they will set a weekly physical activity goal. The primary outcome is feasibility (measured by number of successful text message sessions sent). Secondary outcomes include acceptability and preliminary impact on physical activity, psychological health-, and physical health-related outcomes.
Interventions
BEHAVIORALMove with Meaning
Participants will engage in twice weekly text message sessions, will listen to a weekly audio session, and will work towards a physical activity goal each week, for a total of eight weeks.
Sponsors
Massachusetts General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Masking description
While participants and study trainers will be aware of group assignment, a blinded study team member will perform outcome assessments.
Intervention model description
Randomized, wait-list controlled, blinded intervention trial
Eligibility
Sex/Gender
ALL
Age
45 Years to 64 Years
Healthy volunteers
Yes
Inclusion criteria
* Midlife adults (aged 45-64 years at the time of enrollment) * Suboptimal physical activity (\<150 minutes of moderate to vigorous physical activity, measured by accelerometer) * Access to a phone capable of receiving text messages and listening to audio files (i.e., a smartphone)
Exclusion criteria
* An unrelated condition limiting physical activity * Participation in any other programs focused on cardiac prevention or well-being * A cognitive disturbance precluding participation or informed consent * Current pregnancy * Inability to speak/write fluently in English
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of text message sessions successfully delivered | Weekly over 8 weeks | The automated platform will record rates of successful text message delivery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of audio sessions completed by participants | Weekly over 8 weeks | We will record the number of sessions in which participants engaged (e.g., responded to a text message), out of a total of 8 sessions. |
| Session utility | Weekly over 8 weeks | Participants will rate the utility of each session, measured on a 10-point Likert scale. Higher scores indicate greater utility. |
| Change in overall physical activity (in steps/day) | Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only) | Physical activity (steps) will be measured via an Actigraph accelerometer. We will use established accelerometer protocols to measure the mean number of steps taken per day at each time point. |
| Change in moderate to vigorous physical activity (MVPA; in mean minutes/day) | Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only) | MVPA (reported in mean minutes of MVPA/day) will be measured via an Actigraph accelerometer and recorded in mean minutes/day. |
| Change in sedentary time (in mean minutes/day) | Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only) | Sedentary time (mean minutes/day) will be measured via Actigraph accelerometer. |
| Change in self-reported physical activity (International Physical Activity Questionnaire [IPAQ]; in metabolic equivalent-minutes/week) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | This will be measured via the International Physical Activity Questionnaire (IPAQ) as a secondary measure of physical activity. |
| Change in positive affect (Positive and Negative Affect Schedule [PANAS] positive affect items) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Positive affect (our main psychological outcome given its links to health outcomes and sensitivity to change) will be assessed via the Positive and Negative Affect Schedule (PANAS) positive affect items. PANAS scores range from 10-50, with higher scores indicating higher levels of positive affect. |
| Change in optimism (Life Orientation Test - Revised [LOT-R]) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Optimism will be measured using the Life Orientation Test - Revised (LOT-R), a frequently used 6-item instrument that assesses dispositional optimism. LOT-R scores range from 0-24, with higher scores indicating higher levels of optimism. |
| Change in depressive symptoms (depression subscale of the Hospital Anxiety and Depression Scale [HADS]). | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Depressive symptoms will be measured using the 7-item depression subscale of the Hospital Anxiety and Depression Scale (HADS). The depression subscale of the HADS ranges from 0-21, with higher scores indicating higher levels of depression. |
| Change in anxiety (anxiety subscale of the Hospital Anxiety and Depression Scale [HADS]) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Anxiety will be measured using the 7-item anxiety subscale of the Hospital Anxiety and Depression Scale (HADS). The anxiety subscale of the HADS ranges from 0-21, with higher scores indicating higher levels of anxiety. |
| Change in exercise self-efficacy (Self-Efficacy for Exercise scale [SEE]) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Exercise self-efficacy will be measured via the Self-Efficacy for Exercise (SEE) scale. SEE scores range from 0-90, with higher scores indicating higher levels of self-efficacy for exercise. |
| Change in perceived social support (Multidimensional Scale of Perceived Social Support) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Perceived social support will be measured by the Multidimensional Scale of Perceived Social Support (MSPSS). MSPSS scores range from 1-7, with higher scores indicating higher levels of perceived social support. |
| Change in internal health locus of control (Multidimensional Health Locus of Control [MHLC] scale) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Internal locus/sense of control will be measured using the Multidimensional Health Locus of Control (MHLC) scale. The internal locus of control score from the MHLC ranges from 6-36, with higher scores indicating greater internal locus of control. |
| Change in positive affect during activity (Physical Activity Enjoyment Scale) | Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group) | Positive affect during activity will be measured using the Physical Activity Enjoyment Scale. Physical Activity Enjoyment Scale scores range from 18-126, with higher scores indicating higher levels of enjoyment during activity. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORChristopher M Celano, MD
Massachusetts General Hospital
Outcome results
None listed